MedTrace Logo

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

NCT01688531 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-09-18

No results posted yet for this study

Summary

Exploratory, international, multi-centre, randomized, investigator blinded study in acne

Conditions

Interventions

DRUG

CD0271 0.1%/CD1579 2.5% gel

one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months

DRUG

CD0271 0.1%/CD1579 2.5% gel vehicle

one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Canada
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01688531 on ClinicalTrials.gov